Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes

By Schioth H.B.   Muceniece R.   Larsson M.   Mutulis F.   Szardenings M.   Prusis P.   Lindeberg G.   Wikberg  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 369-373

Elsevier

Access to resources Recommend Favorite

The administration of -melanocyte-stimulating hormone protects the ischemic/reperfused myocardium

By Vecsernyes M.   Juhasz B.   Der P.   Kocsan R.   Feher P.   Bacskay I.   Kovacs P.   Tosaki A.  

European Journal of Pharmacology, Vol. 470, Iss. 3, 2003-06 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

Synthesis and in vitro characterization of new growth hormone secretagogues derived from ipamorelin with dipeptidomimetic N-terminals

By Peschke B.   Ankersen M.   Hansen B.S.   Hansen T.K.   Johansen N.L.   Lau J.   Madsen K.   Petersen H.   Thogersen H.   Watson B.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 5, 1999-05 ,pp. : 363-380

Elsevier

Access to resources Recommend Favorite

The receptor ligand rimcazole alters secretion of prolactin and -melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms

By Eaton M.J.   Lookingland K.J.   Moore K.E.  

European Journal of Pharmacology, Vol. 299, Iss. 1, 1996-03 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

The effects of 2 -melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion

By Herz R.C.G.   De Wildt D.J.   Versteeg D.H.G.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 113-121

Elsevier

Access to resources Recommend Favorite